Skip to content

rTMS Treatment of Spasticity in Children With Cerebral Palsy/ Hemiplegia Due to ABI - a RCT

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Spasticity in Children With Hemiplegic Cerebral Palsy/ Hemiplegia Due to Acquired Brain Injury - a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06128746
Enrollment
20
Registered
2023-11-13
Start date
2024-01-13
Completion date
2026-08-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CP (Cerebral Palsy)

Keywords

TMS, Cerebral palsy, Spasticity

Brief summary

This RCT aims to investigate the effect of repetitive transcranial magnatic stimulation (rTMS) in treating children with hemiplegoc cerebral palsy. The study will measure any improvement in spasticity after using contra-lesional inhibitory rTMS follow by intensive limb training. Participants will attend a 10-day rTMS treatment sessions, follow by intensive training of the impaired limb. They will also undergo MRI scans before and after the treatment to investiagte the underlying neurophysiological mechanisms that lead to changes clinically by using TMS as well as MR-DKI. Researchers will compare the intervention group and the sham group to see if rTMS could result in improvement of participants' spasticity.

Detailed description

Cerebral palsy is the most common cause of lifelong physical disability in childhood, with an estimated prevalence of 1.5 per 1000 living biths for primary school-aged children. Spasticity is the most common symptoms in children with cerebral palsy, leading to muscle weakness affecting gross motor functions and causing complications such as pain, contracture and subluzation which will lead to inability to perform activity-based training and subsequently lead to further muscle weakness. Standard therapy with regular physiotherapy and occupational therapy are essential but time-consuming and the effects might not last for longer duration. Patients or caregivers decline medications because of side effects drowsiness while other interventions such as intra-thecal baclofen pump, rhizotomy or surgery are invasive. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has the ability to modulate excitation of the motor cortex area of the brain. There were past studies suggesting that using contralesional inhibitory rTMS was safe and feasible for patients with paediatric subcortical stroke and seemed to improve hand function in patients with hemiparesis. However, limited studies have been published on the effects of rTMS on improving spasticity in children with cerebral palsy. Hence, the objective of this study is to use low-frequency rTMS to the contra-lesional hemisphere in children with hemiplegic cerebral palsy to investigate if rTMS follow by intensive limb training would improve spasiticity of these children and whether the improvement can be sustained for a longer time. The underlying mechanisms that lead to the changes clinically will also be investigated by TMS and MRI.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

1 Hz rTMS treatment for 20 mins, follow by 30 mins intensive limb training

DEVICESham Repetitive Transcranial Magnetic Stimulation

Sham Hz rTMS treatment for 20 mins, follow by 30 mins intensive limb training

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 7 years and 18 years * Diagnosis of cerebral palsy with hemiplegia * Upper limb spasticity ≥ 1 * IQ ≥ 50

Exclusion criteria

* Any contra-indications to rTMS * Severe spasticity (score of 4 or more in Ashworth scale) * Uncontrollable epilepsy * History of Botulinum toxin A injection in previous 6 months * Upper limb casting in previous 6 months

Design outcomes

Primary

MeasureTime frameDescription
Modified Ashworth ScaleDay 10, 17 of intervention and 2 months post interventionClinical measure of spasticity. Scores range from 0 to 4, with a higher score indicate worse in muscle tone
The range of motion scoresDay 10, 17 of intervention and 2 months post interventionROM of thumb adduction, wrist dorsal flexion and extension, and elbow dorsal flexion and extension. Patients' range of motion score will be compared to the normative values

Secondary

MeasureTime frameDescription
Zancolli scaleDay 10, 17 of intervention and 2 months post interventionSeverity of forearm alignment. Scores range from 0 to 3 with a higher score indicate worse hand function
House functional classification scaleDay 10, 17 of intervention and 2 months post interventionRating of functional use of the impaired upper limb. Scale consists of nine grades from 0 (does not use) to 8 (full spontaneous use)
Gross motor function measureDay 10, 17 of intervention and 2 months post interventionChanges in motor function. A 4-point Likert scale with higher score indicates better motor function
Assisting hand assessmentDay 10, 17 of intervention and 2 months post interventionTest of hand function
Pediatric Quality of Life Cerebral Palsy moduleDay 10, 17 of intervention and 2 months post interventionQuality of life measurement. Scores range from 0 to 100 with higher score indicate better quality of life.
MRI Brain: fMRI and DKIDay 10, 17 of intervention and 2 months post interventionFunctional MRI and Diffusion Kurtosis Imaging measuring the brain microstructural changes and structural connectivity during the intervention

Countries

Hong Kong

Contacts

CONTACTWinnie Wan Yee Tso, MBBS
wytso@hku.hk+85222554295
CONTACTChai Yin Charlie Fan, MPhil, OTR
charliefan@connect.hku.hk+85222554375

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026